Skip to main content

Advertisement

SpringerLink
Log in

Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

An Erratum to this article was published on 11 February 2017

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Change history

  • 11 February 2017

    An erratum to this article has been published.

References

  1. M. Leo, L. Bartalena, G. Rotondo Dottore, E. Piantanida, P. Premoli, I. Ionni, M. Di Cera , E. Masiello, L. Sassi, M.L. Tanda, F. Latrofa, P. Vitti, C. Marcocci, M. Marinò. Effects of selenium on short-term control of hyperthyroidism due to Graves’ disease treated with methimazole: results of a randomized clinical trial. J. Endocrinol. Invest., 2016 [in press]

  2. C. Marcocci, G.J. Kahaly, G.E. Krassas, L. Bartalena, M. Prummel, M. Stahl, M.A. Altea, M. Nardi, S. Pitz, K. Boboridis, P. Sivelli, G. von Arx, M.P. Mourits, L. Baldeschi, W. Bencivelli, W. Wiersinga, Selenium and the course of mild graves’ orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011)

    Article  CAS  PubMed  Google Scholar 

  3. G. Rotondo Dottore, M. Leo, G. Casini, F. Latrofa, L. Cestari, S. Sellari-Franceschini, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Anti-oxidant actions of selenium in orbital fibroblasts: a basis for the effects of selenium in Graves’ Orbitopathy. Thyroid 2016 [in press]

  4. L. Bartalena, Diagnosis and management of Graves’ disease: a global overview. Nat. Rev. Endocrinol. 9, 724–734 (2013)

    Article  CAS  PubMed  Google Scholar 

  5. E. Piantanida, M.L. Tanda, A. Lai, L. Sassi, L. Bartalena, Prevalence and natural history of Graves’ orbitopathy in the XXI century. J. Endocrinol. Invest. 36, 444–449 (2013)

    CAS  PubMed  Google Scholar 

  6. M. Leo, F. Menconi, R. Rocchi, F. Latrofa, E. Sisti, M.A. Profilo, B. Mazzi, E. Albano, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Role of the underlying thyroid disease on the phenotype of Graves’ orbitopathy in a tertiary referral center. Thyroid 25, 347–351 (2015)

    Article  PubMed  Google Scholar 

  7. R.S. Bahn, Current insights into the pathogenesis of Graves’ ophthalmopathy. Horm. Metab. Res. 47, 773–778 (2015)

    Article  CAS  PubMed  Google Scholar 

  8. L.O. Mosnier, J.H. Griffin, Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem. J. 373, 65–70 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. C. Korzeniewski, D.M. Callewaert, An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 25(64), 313–320 (1983)

    Article  Google Scholar 

  10. F. Menconi, M. Leo, P. Vitti, C. Marcocci, M. Marinò, Total thyroid ablation in Graves’ orbitopathy. J. Endocrinol. Invest. 38, 809–815 (2015)

    Article  CAS  PubMed  Google Scholar 

  11. J. Calissendorff, E. Mikulski, E.H. Larsen, M. Möller, A prospective investigation of graves’ disease and selenium: thyroid hormones, auto-antibodies and self-rated symptoms. Eur. Thyroid J. 2, 93–98 (2015)

    Article  Google Scholar 

Download references

Acknowledgements

Unconditionally supported by IBSA Farmaceutici Italia, Lodi, Italy.

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Endocrinology Units, University of Pisa and University Hospital of Pisa, Via Paradisa 2, Pisa, 56124, Italy

    Giovanna Rotondo Dottore, Riccardo Chiarini, Maria De Gregorio, Marenza Leo, Paolo Vitti, Claudio Marcocci & Michele Marinò

  2. Department of Surgical, Medical and Molecular Pathology, Ophthalmopathy Unit I, University of Pisa and University Hospital of Pisa, Via Paradisa 2, Pisa, 56124, Italy

    Giamberto Casini, Luca Cestari & Marco Nardi

  3. Department of Surgical, Medical and Molecular Pathology, ENT Unit I, University of Pisa and University Hospital of Pisa, Italy, Via Paradisa 2, Pisa, 56124, Italy

    Stefano Sellari-Franceschini

Authors
  1. Giovanna Rotondo Dottore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Riccardo Chiarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria De Gregorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marenza Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giamberto Casini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Cestari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefano Sellari-Franceschini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marco Nardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Paolo Vitti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Claudio Marcocci
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michele Marinò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele Marinò.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

The original version of this article was revised: The surname of the coauthor Giovanna Rotondo Dottore was corrected.

Present affiliation: Center for Advanced Biomaterials for Health Care, Italian Institute Of Technology, Naples, Italy.

An erratum to this article is available at https://doi.org/10.1007/s12020-017-1255-z.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rotondo Dottore, G., Chiarini, R., De Gregorio, M. et al. Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy. Endocrine 58, 386–389 (2017). https://doi.org/10.1007/s12020-016-1226-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1226-9

Keywords

Search

Navigation